Eton Pharmaceuticals, Inc. (ETON)
Nasdaq: ETON · Pharmaceutical Preparations · Deer Park, IL · filing with the SEC since 2017
Grade5.7
◀ Past 5.1● Present 6.6▶ Future 5.1
Income statement, as filed
In thousands of US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Period ending | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 |
| Report filed | Mar 19, 2026 | Mar 18, 2025 | Mar 14, 2024 | Mar 16, 2023 | Mar 16, 2022 | Mar 16, 2021 | Mar 5, 2020 | Mar 25, 2019 | · |
| Revenue | 79,950 | 39,011 | 31,642 | 21,251 | 21,832 | 39 | 959 | · | · |
| Cost of revenue | 37,210 | 15,600 | 10,581 | 6,933 | 2,827 | 436r | 453 | · | · |
| Gross profit | 42,740 | 23,411 | 21,061 | 14,318 | 19,005r | -397r | 506 | · | · |
| Research and development | 7,765 | 3,255 | 3,322 | 3,996 | 6,235 | 14,104 | 11,555 | 5,627 | · |
| General and administrative | 35,819 | 22,753 | 18,931 | 18,582 | 14,265r | 12,610r | 7,552 | 4,694 | · |
| Total operating expenses | 43,584 | 26,008 | 22,253 | 22,578 | 20,500r | 26,714r | 19,107 | 10,321 | · |
| Operating income | -844 | -2,597 | -1,192 | -8,260 | -1,495 | -27,111 | -18,601 | -10,321 | · |
| Interest expense | 4,781 | 2,005 | 1,060 | 955 | 1,042 | 884 | 98 | · | · |
| Total non-operating income (expense) | -3,714 | -1,211 | 503 | -761 | -1,006 | -859 | 281 | 164 | · |
| Income before income taxes | -4,558 | -3,808 | -689 | -9,021 | -1,955 | -27,970 | -18,320 | -12,740 | · |
| Income tax expense | 43 | 15 | 247 | 0 | 0 | · | · | · | · |
| Net income including non-controlling interests | · | · | · | · | · | · | · | -12,740 | · |
| Net income | -4,601 | -3,823 | -936 | -9,021 | -1,955 | -27,970 | -18,320 | -12,740 | · |
| Net income to common shareholders | · | · | · | · | · | -27,970 | -18,320 | -37,229 | · |
| Earnings per share, basic | -0.17 | -0.15 | -0.04 | -0.36 | -0.08 | -1.33 | · | · | · |
| Earnings per share, basic and diluted | · | · | · | · | -0.08 | -1.33 | -1.03 | -5.80 | · |
| Weighted average shares, basic | 26,907,725 | 25,895,086 | 25,645,366 | 25,145,657 | 25,207,299 | 21,010,058 | · | · | · |
| Weighted average shares, basic and diluted | · | · | · | · | 25,207,299 | 21,010,058r | 17,760,761r | 6,418,000 | · |
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Revenue what customers paid for what it sold
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTaxCost of revenue what it cost to make or buy what it sold
us-gaap:CostOfGoodsAndServicesSoldGross profit revenue less the cost of what it sold
us-gaap:GrossProfitResearch and development spent on inventing what it sells next
us-gaap:ResearchAndDevelopmentExpenseGeneral and administrative the cost of running the company itself
us-gaap:GeneralAndAdministrativeExpenseTotal operating expenses the running costs together
us-gaap:OperatingExpensesOperating income profit from running the business, before interest and tax
us-gaap:OperatingIncomeLossInterest expense what its borrowing cost
us-gaap:InterestExpenseDebt
us-gaap:InterestExpenseTotal non-operating income (expense) everything outside the business, together
us-gaap:NonoperatingIncomeExpenseIncome before income taxes profit before tax
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestIncome tax expense tax charged on the period's profit
us-gaap:IncomeTaxExpenseBenefitNet income including non-controlling interests the whole group's profit, minority holders' share included
us-gaap:ProfitLossNet income the profit or loss that belongs to the company's shareholders
us-gaap:NetIncomeLossNet income to common shareholders what is left for common shareholders
us-gaap:NetIncomeLossAvailableToCommonStockholdersBasicEarnings per share, basic net income per share outstanding
us-gaap:EarningsPerShareBasicEarnings per share, basic and diluted net income per share, where both counts are the same
us-gaap:EarningsPerShareBasicAndDilutedWeighted average shares, basic the average count of shares outstanding
us-gaap:WeightedAverageNumberOfSharesOutstandingBasicWeighted average shares, basic and diluted the average count, where both counts are the same
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted